On Wednesday—for only the second time—the Food and Drug Administration approved a cutting-edge therapy that genetically modifies a patient’s blood cells in order to attack cancer. This time the therapy, known as CAR T-cell therapy, is designed to treat aggressive non-Hodgkin lymphoma.
Source: The FDA Just Approved Another Promising Immunotherapy For Cancer
Could the Food and Drug Administration classify the Apple Watch as a medical device? It’s a question many have asked over the past couple of years, but the stakes are now higher for the Watch…
Source: Don’t wait for the Apple Watch to dole out medical advice anytime soon | TechCrunch
Three years after IBM began selling Watson for Oncology to recommend cancer treatments, it’s falling short of the lofty expectations IBM created for it.
Source: IBM pitched Watson as a revolution in cancer care. It’s nowhere close
New technology is giving caregivers, family members and physicians a truer glimpse into an illness, helping create more compassionate care and reduce the doctor-patient divide
Source: Can empathy be taught? Toronto company’s technology gives a glimpse into the effects of Parkinson’s – The Globe and Mail
Apple and Aetna have held several secret meetings to discuss offering the Apple Watch to Aetna’s 23 million customers, according to CNBC. Aetna could roll out the plan as early as next year.
Source: Apple reportedly in talks with Aetna to bring the Apple Watch to millions of customers | TechCrunch